Parametric Portfolio Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$8.67M Buy
73,100
+18,226
+33% +$2.27M ﹤0.01% 1465
2021
Q4
$7.56M Sell
54,874
-23,242
-30% -$2.96M ﹤0.01% 1577
2021
Q3
$10.9M Buy
78,116
+31,913
+69% +$3.98M 0.01% 1299
2021
Q2
$4.49M Buy
46,203
+28,171
+156% +$2.29M ﹤0.01% 1917
2021
Q1
$1.23M Sell
18,032
-11,559
-39% -$935K ﹤0.01% 3066
2020
Q4
$2.54M Buy
29,591
+2,948
+11% +$250K ﹤0.01% 2510
2020
Q3
$1.73M Sell
26,643
-2,562
-9% -$168K ﹤0.01% 2595
2020
Q2
$2.13M Buy
29,205
+14,287
+96% +$760K ﹤0.01% 2461
2020
Q1
$508K Buy
14,918
+284
+2% +$13K ﹤0.01% 3151
2019
Q4
$797K Buy
14,634
+6,657
+83% +$330K ﹤0.01% 3168
2019
Q3
$333K Sell
7,977
-18,402
-70% -$777K ﹤0.01% 3492
2019
Q2
$1.16M Buy
26,379
+3,116
+13% +$176K ﹤0.01% 2981
2019
Q1
$1.2M Buy
+23,263
New +$1.01M ﹤0.01% 2938
2017
Q4
Sell
-17,817
Closed -$666K 4033
2017
Q3
$666K Buy
+17,817
New +$540K ﹤0.01% 3265

Other funds holding BHVN